These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 9622507)
21. Conformational changes in yeast phosphoglycerate kinase upon ligand binding: fluorescence of a linked probe and chemical reactivity of genetically introduced cysteinyl residues. Desmadril M; Minard P; Ballery N; Gaillard-Miran S; Hall L; Yon JM Proteins; 1991; 10(4):315-24. PubMed ID: 1946341 [TBL] [Abstract][Full Text] [Related]
22. Nucleotide binding to pig muscle 3-phosphoglycerate kinase in the crystal and in solution: relationship between substrate antagonism and interdomain communication. Merli A; Szilágyi AN; Flachner B; Rossi GL; Vas M Biochemistry; 2002 Jan; 41(1):111-9. PubMed ID: 11772008 [TBL] [Abstract][Full Text] [Related]
23. Direct kinetic evidence that lysine 215 is involved in the phospho-transfer step of human 3-phosphoglycerate kinase. Varga A; Lionne C; Lallemand P; Szabó J; Adamek N; Valentin C; Vas M; Barman T; Chaloin L Biochemistry; 2009 Jul; 48(29):6998-7008. PubMed ID: 19530648 [TBL] [Abstract][Full Text] [Related]
24. Differences in the transient kinetics of the binding of D-ADP and its mirror image L-ADP to human 3-phosphoglycerate kinase revealed by the presence of 3-phosphoglycerate. Gondeau C; Chaloin L; Varga A; Roy B; Lallemand P; Périgaud C; Barman T; Vas M; Lionne C Biochemistry; 2008 Mar; 47(11):3462-73. PubMed ID: 18288812 [TBL] [Abstract][Full Text] [Related]
25. Potentiometric and further kinetic characterization of the flavin-binding domain of Saccharomyces cerevisiae flavocytochrome b2. Inhibition by anions binding in the active site. Cénas N; Lê KH; Terrier M; Lederer F Biochemistry; 2007 Apr; 46(15):4661-70. PubMed ID: 17373777 [TBL] [Abstract][Full Text] [Related]
26. Substrate-induced conformational changes in yeast 3-phosphoglycerate kinase monitored by fluorescence of single tryptophan probes. Cheung CW; Mas MT Protein Sci; 1996 Jun; 5(6):1144-9. PubMed ID: 8762145 [TBL] [Abstract][Full Text] [Related]
27. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase. Klingbeil CK; Gill GN Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496 [TBL] [Abstract][Full Text] [Related]
28. Molecular basis of the unusual catalytic preference for GDP/GTP in Entamoeba histolytica 3-phosphoglycerate kinase. Encalada R; Rojo-Domínguez A; Rodríguez-Zavala JS; Pardo JP; Quezada H; Moreno-Sánchez R; Saavedra E FEBS J; 2009 Apr; 276(7):2037-47. PubMed ID: 19292872 [TBL] [Abstract][Full Text] [Related]
29. Mapping the active sites of 3-phosphoglycerate kinase and glycerol kinase with monoammine chromium(III) ATP. Lester LM; Rusch LA; Robinson GJ; Speckhard DC Biochemistry; 1998 Apr; 37(16):5349-55. PubMed ID: 9548916 [TBL] [Abstract][Full Text] [Related]
30. A model for the regulation of D-3-phosphoglycerate dehydrogenase, a Vmax-type allosteric enzyme. Grant GA; Schuller DJ; Banaszak LJ Protein Sci; 1996 Jan; 5(1):34-41. PubMed ID: 8771194 [TBL] [Abstract][Full Text] [Related]
31. Identification of specific interactions that drive ligand-induced closure in five enzymes with classic domain movements. Hayward S J Mol Biol; 2004 Jun; 339(4):1001-21. PubMed ID: 15165865 [TBL] [Abstract][Full Text] [Related]
32. Role of side-chains in the operation of the main molecular hinge of 3-phosphoglycerate kinase. Szabó J; Varga A; Flachner B; Konarev PV; Svergun DI; Závodszky P; Vas M FEBS Lett; 2008 Apr; 582(9):1335-40. PubMed ID: 18358841 [TBL] [Abstract][Full Text] [Related]
33. Antagonistic binding of substrates to 3-phosphoglycerate kinase monitored by the fluorescent analogue 2'(3')-O-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate. Vas M; Merli A; Rossi GL Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):885-91. PubMed ID: 8053912 [TBL] [Abstract][Full Text] [Related]
34. Cryoenzymic studies on yeast 3-phosphoglycerate kinase. Attempt to obtain the kinetics of the hinge-bending motion. Geerlof A; Schmidt PP; Travers F; Barman T Biochemistry; 1997 May; 36(18):5538-45. PubMed ID: 9154937 [TBL] [Abstract][Full Text] [Related]
35. Modeling of solvent flow effects in enzyme catalysis under physiological conditions. Schofield J; Inder P; Kapral R J Chem Phys; 2012 May; 136(20):205101. PubMed ID: 22667589 [TBL] [Abstract][Full Text] [Related]
36. [Rat liver phosphoglycerate kinase. I. Purification and kinetic properties in the biosynthesis of 1-3 diphosphoglycerate]. Lavoinne A; Marchand JC; Chedeville A; Matray F Biochimie; 1979; 61(9):1043-53. PubMed ID: 534662 [TBL] [Abstract][Full Text] [Related]
37. The effects of ligands on the conformation of phosphoglycerate kinase: fluorescence anisotropy decay and theoretical interpretation. Mouawad L; Desmadril M; Perahia D; Yon JM; Brochon JC Biopolymers; 1990; 30(13-14):1151-60. PubMed ID: 2085655 [TBL] [Abstract][Full Text] [Related]
38. Domain motions and the open-to-closed conformational transition of an enzyme: a normal mode analysis of S-adenosyl-L-homocysteine hydrolase. Wang M; Borchardt RT; Schowen RL; Kuczera K Biochemistry; 2005 May; 44(19):7228-39. PubMed ID: 15882061 [TBL] [Abstract][Full Text] [Related]
39. Crystallographic and thiol-reactivity studies on the complex of pig muscle phosphoglycerate kinase with ATP analogues: correlation between nucleotide binding mode and helix flexibility. Kovári Z; Flachner B; Náray-Szabó G; Vas M Biochemistry; 2002 Jul; 41(28):8796-806. PubMed ID: 12102622 [TBL] [Abstract][Full Text] [Related]